The thought of cold open-water swimming might be enough to set your goosebumps off, but after a deep dive into the why, the benefits certainly outweigh the initial chill Floating, weightlessness, resilience, and total freedom – that’s what swimming means to me. So imagine those feelings combined with the sun on your back, the scent
0 Comments
Race and insurance status appear to influence whether patients receive stroke treatment with thrombolysis and endovascular therapy (EVT), new research shows. In a study of data from three states, investigators found that black patients were 18% to 35% less likely to receive thrombolysis and 31% less likely to receive EVT than their white counterparts. In
0 Comments
Meaningful legislation addressing health care inequities in the U.S. will require studies examining potential health disparities due to geographic location or economic status. An interdisciplinary team at the Medical University of South Carolina (MUSC) and the University of South Carolina (UofSC) report in the Journal of Public Health Dentistry that rural children are less likely
0 Comments
President Biden said the nation has administered 200 million COVID-19 vaccines in his first 100 days, and promoted a small businesses tax credit allowing paid leave for employees who get vaccinated. “Today we hit 200 million shots,” he said at a Wednesday press conference. Under the $1.9 trillion American Rescue Plan, which Congress passed and
0 Comments
I remember times in my life when everything seemed totally overwhelming. I just did not know what to do. Life felt like it had kicked the breath totally out of me. Have you experienced those kinds of difficult periods? Sometimes they come around loss … of job, of health, of a precious person. Sometimes they
0 Comments
Patients with cancer face an increased risk of arterial thromboembolic events, including myocardial infarction (MI) and stroke, and for some that risk appears substantial, according to a new population-based study. For example, the 6-month incidence of arterial thromboembolism (ATE) was 4.09% among men older than age 75 with diabetes and a diagnosis of bladder cancer
0 Comments
Mosquitos are attracted to blood, and they bite to get their “food”.1 Mosquito bites are rarely felt, and often they aren’t noticed until hours later. Mosquito bites are generally harmless, but sometimes they pose serious health concerns. Mosquitos can carry diseases, so they can end up passing on illnesses when they bite.1 Symptoms of mosquito
0 Comments
In this article EBS The Emergent BioSolutions plant, a manufacturing partner for Johnson & Johnson’s Covid-19 vaccine, in Baltimore, Maryland, on April 9, 2021. Saul Loeb | AFP | Getty Images Top House Democrats have launched an investigation into whether Emergent Biosolutions, which recently botched 15 million doses of Covid-19 vaccine, won the federal contract
0 Comments
Reap the rewards of spending time outside this May. Prioritise self-care, and explore new-found joys in nature 1. Page-turners Watermarks: Life, Death and Swimming by Lenka Janiurek Reading about the experiences of others, particularly those that we would not otherwise be exposed to, can help to open our eyes and broaden our perspectives. Lenka’s heartwarming
0 Comments
A COVID-19 vaccine that could provide protection against existing and future strains of the COVID-19 coronavirus, and other coronaviruses, and cost about $1 a dose has shown promising results in early animal testing. Vaccines created by UVA Health’s Steven L. Zeichner, MD, PhD, and Virginia Tech’s Xiang-Jin Meng, MD, PhD, prevented pigs from being becoming
0 Comments
INDIANAPOLIS, April 16, 2021 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) has requested the U.S. Food and Drug Administration (FDA) revoke the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg alone. Lilly made this request due to the evolving variant landscape in the U.S. and the full availability of bamlanivimab and etesevimab together. This request
0 Comments
pacritinib Treatment for Myelofibrosis CTI BioPharma Announces Completion of Rolling Submission of New Drug Application (NDA) for Pacritinib in Myelofibrosis Patients with Severe Thrombocytopenia SEATTLE, March 31, 2021 /PRNewswire/ – CTI BioPharma Corp. (Nasdaq: CTIC) today announced that it has completed a rolling New Drug Application (“NDA”) submission to the U.S. Food and Drug Administration (“FDA”) seeking approval of pacritinib as
0 Comments
Tisotumab vedotin (Seagen/Genlab), an investigational antibody drug conjugate directed against tissue factor, has shown promise for patients with recurrent or metastatic cervical cancer. When used as monotherapy in previously treated patients, the drug showed “clinically meaningful and durable” antitumor activity. The confirmed objective response rate (ORR) was 24% and included seven (7%) complete responses and
0 Comments
At least 55% of India’s population should be immune to Covid-19 by September, pushing the country toward population immunity, according to the managing director of a local health-care group. Suneeta Reddy of Apollo Hospitals said around 122 million doses of vaccines have been administered in India since the rollout began in January. “We currently believe
0 Comments
A team of researchers from the Hebrew University of Jerusalem has proven the linkages between ultra-processed foods and reduced bone quality, unveiling the damage of these foods particularly for younger children in their developing years. The study, led by Professor Efrat Monsonego-Ornan and Dr. Janna Zaretsky from the Department of Biochemistry, Food Science and Nutrition
0 Comments
Researchers identified two potential drug candidates that can inhibit SARS-CoV-2 in vitro. Their combination can work synergistically and increase their inhibitory effect. Although several vaccines have now been approved to combat COVID-19, not enough is known about their efficacy against new variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Available treatments target the
0 Comments
ROUND ROCK, Texas, April 19, 2021 /PRNewswire/ — ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the diagnosis and treatment of allergies, announced that the U.S. Food and Drug Administration (FDA) approved Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use for the
0 Comments